SCHEMBL3884828

SCHEMBL3884828

Cc1cccc(-c2cc3ccccn3c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.58
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
MAPT P10636 3/20 0.58
ALDH1A1 P00352 2/20 0.58
POLB P06746 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HRH3 Q9Y5N1 4/20 0.46
TSHR P16473 3/20 0.38
ALOX15 P16050 1/20 0.38
HPGD P15428 1/20 0.38
ENPP3 O14638 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ACHE P22303 1/20 0.37
TGFBR1 P36897 1/20 0.36
TGFBR2 P37173 1/20 0.36
TRPV1 Q8NER1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873426 0.82 ALDH1A1 (0.62) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL942764 0.81 ALDH1A1 (0.65) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL3897325 0.79 ALDH1A1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL1850566 0.79 NPC1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL3895951 0.79 ALDH1A1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL30088573 0.79 NPC1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL29089654 0.79 NPC1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL1851663 0.79 NPC1 (0.58) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL27278125 0.79 MAPT (0.54) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
Dimethylamine SCHEMBL7169891 0.79 ALDH1A1 (0.57) SMN1; SMN2NPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108129480-A A kind of preparation method of the indolizine of methylene containing heteroaromatic derivative 赵艳阳 2018-06-08 CN claimed
CN-117265556-A Electrochemical preparation method and application of 1, 3-diaryl mercapto indolizine derivative 上海陶术生物科技有限公司 2023-12-22 CN disclosed
CN-108129480-A A kind of preparation method of the indolizine of methylene containing heteroaromatic derivative 赵艳阳 2018-06-08 CN disclosed
US-8486962-B2 N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus F2G LTD. (GB) 2013-07-16 US disclosed
EP-1888063-B1 ANTIFUNGAL AGENTS F2G LTD (GB) 2009-01-14 EP disclosed
US-20080161302-A1 N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus F2G LTD. (GB) 2008-07-03 US disclosed
EP-1888063-A1 ANTIFUNGAL AGENTS F2G Ltd. (GB) 2008-02-20 EP disclosed
WO-2006123145-A1 ANTIFUNGAL AGENTS F2G LTD (GB) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161302-A1 N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus NAT1, CYP1A2, CYP51A1 SMN1; SMN2 3501/4885NPC1 1899/4885RAB9A 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.